Kratom; add to Schedule I of the Uniform Controlled Substances Act.

H. B. No. 864 *HR43/R112* ~ OFFICIAL ~ G1/2
26/HR43/R112
PAGE 1 (MCL\KP)

To: Business and Commerce;
Drug Policy
MISSISSIPPI LEGISLATURE REGULAR SESSION 2026

By: Representative Bell (21st)

HOUSE BILL NO. 864

AN ACT TO AMEND SECTION 41-29-113, MISSISSIPPI CODE OF 1972, 1
TO ADD KRATOM TO SCHEDULE I OF THE UNIFORM CONTROLLED SUBSTANCES 2
ACT; AND FOR RELATED PURPOSES. 3
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI: 4
SECTION 1. Section 41-29-113, Mississippi Code of 1972, is 5
amended as follows: 6
41-29-113. 7
SCHEDULE I 8
(a) Schedule I consists of the drugs and other substances, 9
by whatever official name, common or usual name, chemical name, or 10
brand name designated, that is listed in this section. 11
(b) Opiates. Unless specifically excepted or unless listed 12
in another schedule, any of the following opiates, including their 13
isomers, esters, ethers, salts and salts of isomers, esters and 14
ethers, whenever the existence of these isomers, esters, ethers 15
and salts is possible within the specific chemical designation: 16
(1) Acetyl-alpha-methylfentanyl 17
(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide); 18
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 2 (MCL\KP)

(2) Acetylmethadol; 19
(3) Acetyl fentanyl 20
(N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); 21
(4) Acryl fentanyl 22
(N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide), also known as 23
acryloylfentanyl; 24
(5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino) 25
cyclohexylmethyl]benzamide); 26
(6) Allylprodine; 27
(7) Alphacetylmethadol, except levo-alphacetylmethadol 28
(levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM); 29
(8) Alphameprodine; 30
(9) Alphamethadol; 31
(10) Alpha′-methyl butyryl fentanyl 32
(2-methyl-N-1-phenethylpiperidin-4-yl)-N-phenylbutanamide); 33
(11) Alpha-Methylfentanyl 34
(N-[1-alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 35
1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine); 36
(12) Alpha-Methylthiofentanyl 37
(N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide38
); 39
(13) Benzethidine; 40
(14) Betacetylmethadol; 41
(15) Beta-Hydroxyfentanyl 42
(N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide); 43
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 3 (MCL\KP)

(16) Beta-Hydroxy-3-methylfentanyl 44
(N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpr45
opanamide); 46
(17) Beta-Hydroxythiofentanyl 47
(N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpr48
opionamide); 49
(18) Betameprodine; 50
(19) Betamethadol; 51
(20) Beta-Methyl fentanyl 52
(N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide), also 53
known as β-methyl fentanyl; 54
(21) Beta'-Phenyl fentanyl 55
(N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide), also 56
known as β'-phenyl fentanyl or 3-phenylpropanoyl fentanyl; 57
(22) Betaprodine; 58
(23) Brorphine (1–(1–(1–59
(4-bromophenyl)ethyl)piperidin-4–yl)–60
1,3-dihydro-2H-benzo[d]imidazol-2-one); 61
(24) Butyrl fentanyl 62
(N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide); 63
(25) Clonitazene; 64
(26) Crotonyl fentanyl 65
((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide); 66
(27) Cyclopentyl fentanyl 67
(N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide); 68
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 4 (MCL\KP)

(28) Cyclopropyl fentanyl 69
(N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide); 70
(29) Dextromoramide; 71
(30) Diampromide; 72
(31) Diethylthiambutene; 73
(32) Difenoxin; 74
(33) Dimenoxadol; 75
(34) Dimepheptanol; 76
(35) 2′,5′-dimethoxyfentanyl 77
(N-1-2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide); 78
(36) Dimethylthiambutene; 79
(37) Dioxaphetyl butyrate; 80
(38) Dipipanone; 81
(39) Ethylmethylthiambutene; 82
(40) Etodesnitazene 83
(2-2-4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amin84
e, also known as etazene; 85
(41) Etonitazene; 86
(42) Etoxeridine; 87
(43) Fentanyl carbamate 88
(ethyl(1-phenethylpiperidin-4-yl)(phenyl)carbamate); 89
(44) Fentanyl-related substances, meaning any substance 90
not otherwise listed under another schedule and for which no 91
exemption or approval is in effect under Section 505 of the 92
Federal Food, Drug, and Cosmetic Act [21 USC 355] that is 93
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 5 (MCL\KP)

structurally related to fentanyl by one or more of the following 94
modifications: 95
(A) Replacement of the phenyl portion of the 96
phenethyl group by any monocycle, whether or not further 97
substituted in or on the monocycle; 98
(B) Substitution in or on the phenethyl group with 99
alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro 100
groups; 101
(C) Substitution in or on the piperidine ring with 102
alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, 103
amino or nitro groups; 104
(D) Replacement of the aniline ring with any 105
aromatic monocycle whether or not further substituted in or on the 106
aromatic monocycle; and/or 107
(E) Replacement of the N-propionyl group by 108
another acyl group. 109
(45) 4-Fluoroisobutyryl fentanyl 110
(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide), 111
also known as para-fluoroisobutyryl fentanyl); 112
(46) 2'-Fluoro ortho-fluorofentanyl 113
(N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl) 114
propionamide), also known as 2'-fluoro 2-fluorofentanyl; 115
(47) Furanyl fentanyl 116
(N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide); 117
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 6 (MCL\KP)

(48) 3-furanyl fentanyl 118
(N-1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide); 119
(49) Furethidine; 120
(50) Hydroxypethidine; 121
(51) Isobutyryl fentanyl 122
(N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide); 123
(52) Isotonitazene (N,N-diethyl-2-(2-(4 124
isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine); 125
(53) Isovaleryl fentanyl 126
(3-methyl-N-1-phenethylpiperidin-4-yl)-N-phenylbutanamide); 127
(54) Ketobemidone (including the optical and geometric 128
isomers); 129
(55) Levomoramide; 130
(56) Levophenacylmorphan; 131
(57) Meta-fluorofentanyl 132
(N-3-fluorophenyl)-N-1-phenethylpiperidin-4-yl)propionamide); 133
(58) Meta-fluoroisobutyryl fentanyl 134
(N-(3-fluorophenyl)-N-1-phenethylpiperidin-4-yl)isobutyramide); 135
(59) Methoxyacetyl fentanyl 136
(2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); 137
(60) 4'-Methyl acetyl fentanyl 138
(N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide); 139
(61) 2-methyl AP–237 140
(1-2-methyl-4-3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one; 141
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 7 (MCL\KP)

(62) 3-Methylfentanyl 142
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide); 143
(63) 3-Methylthiofentanyl (N-[3-methyl-1- 144
(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide); 145
(64) Para-methoxyfuranyl fentanyl 146
(N-(4-methoxyphenyl)-N-1-phenethylpiperidin-4-yl)furan-2-carboxami147
de); 148
(65) Metonitazene 149
(N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)e150
than-1-amine (metonitazene); 151
(66) Morpheridine; 152
(67) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine); 153
(68) MT-45 154
(1-cyclohexyl-4-(1,2-diphenylethyl)piperazine); 155
(69) N-pyrrolidino etonitazene 156
2-4-ethoxybenzyl)-5-nitro-1-2-pyrrolidin-1-yl)ethyl)-1H-benzimidaz157
ole, also known as etonitazepyne; 158
(70) Noracymethadol; 159
(71) Norlevorphanol; 160
(72) Normethadone; 161
(73) Norpipanone; 162
(74) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N- 163
(1-phenethylpiperidin-4-yl)acetamide); 164
(75) Ortho-Fluoroacryl fentanyl 165
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide); 166
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 8 (MCL\KP)

(76) Ortho-Fluorobutyryl fentanyl 167
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide), also 168
known as 2-fluorobutyryl fentanyl; 169
(77) Ortho-Fluorofentanyl 170
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide), 171
also known as 2-fluorofentanyl; 172
(78) Ortho-fluorofuranyl fentanyl 173
(N-2-fluorophenyl)-N-1-phenethylpiperidin-4-yl)furan-2-carboxamide174
); 175
(79) Ortho-Fluoroisobutyryl fentanyl 176
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide); 177
(80) Ortho-Methyl acetylfentanyl 178
(N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide), also 179
known as 2-methyl acetylfentanyl; 180
(81) Ortho-Methyl methoxyacetyl fentanyl 181
(2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl) 182
acetamide), also known as 2-methyl methoxyacetyl fentanyl; 183
(82) Para-Chloroisobutyryl fentanyl 184
(N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide); 185
(83) Para-Fluorobutyryl fentanyl 186
(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide); 187
(84) Para-Fluorofentanyl (N-(4-fluorophenyl) 188
-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide); 189
(85) Para-Fluoro furanyl fentanyl N-(4-fluorophenyl)-N- 190
(1-phenethylpiperidin-4-yl)furan-2-carboxamide); 191
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 9 (MCL\KP)

(86) Para-Methoxybutyryl fentanyl 192
(N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide); 193
(87) Para-methylcyclopropyl fentanyl 194
(N-4-methylphenyl)-N-1-phenethylpiperidin-4-yl)cyclopropanecarboxa195
mide); 196
(88) Para-Methylfentanyl 197
(N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide), 198
also known as 4-methylfentanyl); 199
(89) PEPAP 200
(1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine); 201
(90) Phenadoxone; 202
(91) Phenampromide; 203
(92) Phenomorphan; 204
(93) Phenoperidine; 205
(94) Phenyl fentanyl 206
(N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide), also known as 207
benzoyl fentanyl; 208
(95) Piritramide; 209
(96) Proheptazine; 210
(97) Properidine; 211
(98) Propiram; 212
(99) Protonitazene 213
N,N-diethyl-2-5-nitro-2-4-propoxybenzyl)-1H-benzimidazol-1-yl)etha214
n-1-amine; 215
(100) Racemoramide; 216
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 10 (MCL\KP)

(101) Tetrahydrofuranyl fentanyl 217
(N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2- 218
carboxamide); 219
(102) Thiofentanyl 220
(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide); 221
(103) Thiofuranyl fentanyl 222
(N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide), 223
also known as 2-thiofuranyl fentanyl or thiophene fentanyl; 224
(104) Tilidine; 225
(105) Trimeperidine; 226
(106) U-47700, (3,4-dichloro-N- 227
[2-(dimethylamino)cyclohexyl]-N-methylbenzamide); 228
(107) Valeryl fentanyl 229
(N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide). 230
(c) Opium derivatives. Unless specifically excepted or 231
unless listed in another schedule, any of the following opium 232
derivatives, their salts, isomers and salts of isomers, whenever 233
the existence of these salts, isomers and salts of isomers is 234
possible within the specific chemical designation: 235
(1) Acetorphine; 236
(2) Acetyldihydrocodeine; 237
(3) Benzylmorphine; 238
(4) Codeine methylbromide; 239
(5) Codeine-N-Oxide; 240
(6) Cyprenorphine; 241
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 11 (MCL\KP)

(7) Desomorphine; 242
(8) Dihydromorphine; 243
(9) Drotebanol; 244
(10) Etorphine (except hydrochloride salt); 245
(11) Heroin; 246
(12) Hydromorphinol; 247
(13) Methyldesorphine; 248
(14) Methyldihydromorphine; 249
(15) Monoacetylmorphine; 250
(16) Morphine methylbromide; 251
(17) Morphine methylsulfonate; 252
(18) Morphine-N-Oxide; 253
(19) Myrophine; 254
(20) Nicocodeine; 255
(21) Nicomorphine; 256
(22) Normorphine; 257
(23) Pholcodine; 258
(24) Thebacon. 259
(d) Hallucinogenic substances. Unless specifically excepted 260
or unless listed in another schedule, any material, compound, 261
mixture or preparation which contains any quantity of the 262
following substances, their salts, isomers (whether optical, 263
positional, or geometric) and salts of isomers, whenever the 264
existence of these salts, isomers and salts of isomers is possible 265
within the specific chemical designation: 266
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 12 (MCL\KP)

(1) Alpha-ethyltryptamine; 267
(2) 4-bromo-2,5-dimethoxy-amphetamine; 268
(3) 4-bromo-2,5-dimethoxyphenethylamine; 269
(4) 2,5-dimethoxyamphetamine; 270
(5) 2,5-dimethoxy-4-ethylamphetamine (DOET); 271
(6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine 272
(2C-T-7); 273
(7) 4-methoxyamphetamine; 274
(8) 5-methoxy-3,4-methylenedioxy-amphetamine; 275
(9) 4-methyl-2,5-dimethoxy-amphetamine; 276
(10) 3,4-methylenedioxy amphetamine; 277
(11) 3,4-methylenedioxymethamphetamine (MDMA); 278
(12) 3,4-methylenedioxy-N-ethylamphetamine (also known 279
as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl 280
MDA, MDE, MDEA); 281
(13) N-hydroxy-3,4-methylenedioxyamphetamine (also 282
known as N-hydroxy MDA, N-OHMDA, and 283
N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine); 284
(14) 3,4,5-trimethoxy amphetamine; 285
(15) 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT); 286
(16) Alpha-methyltryptamine (also known as AMT); 287
(17) Bufotenine; 288
(18) Diethyltryptamine; 289
(19) Dimethyltryptamine; 290
(20) 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT); 291
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 13 (MCL\KP)

(21) Ibogaine; 292
(22) Lysergic acid diethylamide (LSD); 293
(23) (A) Marijuana (Hemp as defined and regulated 294
under Sections 69-25-201 through 69-25-221 and Cannabidiol 295
contained in a legend drug product approved by the Federal Food 296
and Drug Administration or obtained under Section 41-29-136 are 297
exempt under Schedule I); 298
(B) Hashish; 299
(24) Mescaline; 300
(25) Parahexyl; 301
(26) Peyote; 302
(27) N-ethyl-3-piperidyl benzilate; 303
(28) N-methyl-3-piperidyl benzilate; 304
(29) Psilocybin; 305
(30) Psilocyn; 306
(31) Tetrahydrocannabinols, meaning 307
tetrahydrocannabinols contained in a plant of the genus Cannabis 308
(cannabis plant), as well as the synthetic equivalents of the 309
substances contained in the cannabis plant, or in the resinous 310
extractives of such plant, and/or synthetic substances, 311
derivatives, and their isomers with similar chemical structure and 312
pharmacological activity to those substances contained in the 313
plant such as the following: 314
(A) 1 cis or trans tetrahydrocannabinol; 315
(B) 6 cis or trans tetrahydrocannabinol; 316
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 14 (MCL\KP)

(C) 3,4 cis or trans tetrahydrocannabinol. 317
(Since nomenclature of these substances is not 318
internationally standardized, compounds of these structures, 319
regardless of atomic positions, are covered.) 320
("Tetrahydrocannabinols" excludes dronabinol and nabilone.) 321
For purposes of this paragraph, tetrahydrocannabinols do not 322
include hemp or hemp products regulated under Sections 69-25-201 323
through 69-25-221. 324
However, the following products are exempted from control: 325
(i) THC-containing industrial products made 326
from cannabis stalks (e.g., paper, rope and clothing); 327
(ii) Processed cannabis plant materials used 328
for industrial purposes, such as fiber retted from cannabis stalks 329
for use in manufacturing textiles or rope; 330
(iii) Animal feed mixtures that contain 331
sterilized cannabis seeds and other ingredients (not derived from 332
the cannabis plant) in a formula designed, marketed and 333
distributed for nonhuman consumption; 334
(iv) Personal care products that contain oil 335
from sterilized cannabis seeds, such as shampoos, soaps, and body 336
lotions (if the products do not cause THC to enter the human 337
body); 338
(v) Hemp as regulated under Sections 339
69-25-201 through 69-25-221; and 340
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 15 (MCL\KP)

(vi) Any product derived from the hemp plant 341
designed for human ingestion and/or consumption that is approved 342
by the United States Food and Drug Administration; 343
(32) Phencyclidine; 344
(33) Ethylamine analog of phencyclidine (PCE); 345
(34) Pyrrolidine analog of phencyclidine (PHP, PCPy); 346
(35) Thiophene analog of phencyclidine; 347
(36) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine (TCPy); 348
(37) 4-methylmethcathinone (mephedrone); 349
(38) 3,4-methylenedioxypyrovalerone (MDPV); 350
(39) 2-(2,5-dimethoxy-4-ethylphenyl)ethanamine (2C-E); 351
(40) 2-(2,5-dimethoxy-4-methylphenyl)ethanamine (2C-D); 352
(41) 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine (2C-C); 353
(42) 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine (2C-I); 354
or 2,5-dimethoxy-4-iodophenethylamine; 355
(43) 2-[4-(ethylthio)-2,5-dimethoxyphenyl]ethanamine 356
(2C-T-2); 357
(44) 358
2-[4-(isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4); 359
(45) 2-(2,5-dimethoxyphenyl)ethanamine (2C-H); 360
(46) 2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine (2C-N); 361
(47) 2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine 362
(2C-P); 363
(48) 3,4-methylenedioxy-N-methylcathinone(methylone); 364
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 16 (MCL\KP)

(49) 365
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine 366
(25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36); 367
(50) 368
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine 369
(25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82); 370
(51) 371
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine or 372
N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; 373
Cimbi-5); 374
(52) 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1, 375
4-benzodiazepin-2-one (also known as Phenazepam); 376
(53) 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8, 377
11,12-tetraazatricyclo[8.3.0.0]trideca-2(6),4,7,10,12-pentaene 378
(also known as Etizolam); 379
(54) Salvia divinorum; 380
(55) Synthetic cannabinoids. Unless specifically 381
excepted or unless listed in another schedule, any material, 382
compound, mixture, or preparation which contains any quantity of a 383
synthetic cannabinoid found in any of the following chemical 384
groups, whether or not substituted to any extent, or any of those 385
groups which contain any synthetic cannabinoid salts, isomers, or 386
salts of isomers, whenever the existence of such salts, isomers, 387
or salts of isomers is possible within the specific chemical 388
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 17 (MCL\KP)

designation, including all synthetic cannabinoid chemical 389
analogues in such groups: 390
(A) (6aR,10aR)-9-(hydroxymethyl)-6, 391
6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] 392
chromen-1-ol (also known as HU-210 or 393
1,1-dimethylheptyl-11-hydroxy-delta8-tetrahydrocannabinol); 394
(B) Naphthoylindoles and naphthylmethylindoles, 395
being any compound structurally derived from 3-(1-naphthoyl)indole 396
or 1H-indol-3-yl-(1-naphthyl)methane, whether or not substituted 397
in the indole ring to any extent, or in the naphthyl ring to any 398
extent; 399
(C) Naphthoylpyrroles, being any compound 400
structurally derived from 3-(1-naphthoyl)pyrrole, whether or not 401
substituted in the pyrrole ring to any extent, or in the naphthyl 402
ring to any extent; 403
(D) Naphthylmethylindenes, being any compound 404
structurally derived from 1-(1-naphthylmethyl)indene, whether or 405
not substituted in the indene ring to any extent or in the 406
naphthyl ring to any extent; 407
(E) Phenylacetylindoles, being any compound 408
structurally derived from 3-phenylacetylindole, whether or not 409
substituted in the indole ring to any extent or in the phenyl ring 410
to any extent; 411
(F) Cyclohexylphenols, being any compound 412
structurally derived from 2-(3-hydroxycyclohexyl)phenol, whether 413
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 18 (MCL\KP)

or not substituted in the cyclohexyl ring to any extent or in the 414
phenolic ring to any extent; 415
(G) Benzoylindoles, whether or not substituted in 416
the indole ring to any extent or in the phenyl ring to any extent; 417
(H) Adamantoylindoles, whether or not substituted 418
in the indole ring to any extent or in the adamantoyl ring system 419
to any extent; 420
(I) Tetrahydro derivatives of cannabinol and 421
3-alkyl homologues of cannabinol or of its tetrahydro derivatives, 422
except where contained in cannabis or cannabis resin; 423
(J) 3-Cyclopropylmethanone indole or 424
3-Cyclobutylmethanone indole or 3-Cyclopentylmethanone indole by 425
substitution at the nitrogen atom of the indole ring, whether or 426
not further substituted in the indole ring to any extent, whether 427
or not substituted on the cyclopropyl, cyclobutyl or cyclopentyl 428
rings to any extent; 429
(K) Quinolinyl ester indoles, being any compound 430
structurally derived from 1H-indole-3carboxylic acid-8-quinolinyl 431
ester, whether or not substituted in the indole ring to any extent 432
or the quinolone ring to any extent; 433
(L) 3-carboxamide-1H-indazoles, whether or not 434
substituted in the indazole ring to any extent and substituted to 435
any degree on the carboxamide nitrogen and 436
3-carboxamide-1H-indoles, whether or not substituted in the indole 437
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 19 (MCL\KP)

ring to any extent and substituted to any degree on the 438
carboxamide nitrogen; 439
(M) Cycloalkanemethanone Indoles, whether or not 440
substituted at the nitrogen atom on the indole ring, whether or 441
not further substituted in the indole ring to any extent, whether 442
or not substituted on the cycloalkane ring to any extent; 443
(56) Naphthalen-1-yl 444
1-(5-fluoropentyl)-1H-indole-3-carboxylate, also known as NM2201 445
or CBL2201; 446
(57) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H- 447
pyrrolo[2,3-b]pyridine-3-carboxamide, also known as 448
5F-CUMYL-P7AICA or SGT-25; 449
(58) Methyl 450
2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutano451
ate, also known as 4F-MDMB-BINACA or 4F-MDMB-BUTINACA); 452
(59) 1-(4-methoxyphenyl)-N-methylpropan-2-amine, also 453
known as para-methoxymethamphetamine or PMMA; 454
(60) Ethyl 2-(1-(5-fluoropentyl) 455
-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, also known as 456
5F-EDMB-PINACA; 457
(61) Methyl 458
2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoa459
te, also known as 5F-MDMB-PICA or 5F-MDMB-2201; 460
(62) 461
N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, 462
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 20 (MCL\KP)

also known as FUB-AKB48 or FUB-APINACA or AKB48 463
N-(4-fluorobenzyl); 464
(63) 465
(1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)466
methanone, also known as FUB-144; 467
(64) N-ethylhexedrone, also known as 468
α-ethylaminohexanophenone or 2-(ethylamino)-1-phenylhexan-1-one; 469
(65) Alpha-pyrrolidinohexanophenone, also known as 470
α-PHP or α-pyrrolidinohexanophenone or 471
1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one); 472
(66) 4-methyl-alpha-ethylaminopentiophenone, also known 473
as 4-MEAP or 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one); 474
(67) 4'-methyl-alpha-pyrrolidinohexiophenone, also 475
known as MPHP or 4'-methyl-alpha-pyrrolidinohexanophenone or 476
1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one); 477
(68) Alpha-pyrrolidinoheptaphenone (also known as PV8; 478
1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one); 479
(69) 4'-chloro-alpha-pyrrolidinovalerophenone, also 480
known as 4-chloro-α-PVP or 4'-chloro-α-pyrrolidinopentiophenone or 481
1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one); 482
(70) 483
2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one, also known as 484
methoxetamine or MXE; 485
(71) Zipeprol 486
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 21 (MCL\KP)

(1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylp487
ropan-2-ol); 488
(72) Eutylone 489
(1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one); and 490
(73) ADB–BUTINACA 491
N-1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carb492
oxamide. 493
(e) Depressants. Unless specifically excepted or unless 494
listed in another schedule, any material, compound, mixture, or 495
preparation which contains any quantity of the following 496
substances having a depressant effect on the central nervous 497
system, including their salts, isomers, and salts of isomers, 498
whenever the existence of such salts, isomers, and salts of 499
isomers is possible within the specific chemical designation: 500
(1) Clonazolam, 501
6-(2-chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]502
benzodiazepine; 503
(2) Flualprazolam, 504
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4505
]benzodiazepine; 506
(3) Flubromazepam, 507
7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 508
(4) Flubromazolam, 509
8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]510
benzodiazepin; 511
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 22 (MCL\KP)

(5) Gamma-hydroxybutyric acid (other names include: 512
GHB, gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic 513
acid; sodium oxybate; sodium oxybutyrate); 514
(6) Mecloqualone; 515
(7) Methaqualone. 516
(f) Stimulants. Any material, compound, mixture or 517
preparation which contains any quantity of the following central 518
nervous system stimulants including optical salts, isomers and 519
salts of isomers unless specifically excepted or unless listed in 520
another schedule: 521
(1) Aminorex; 522
(2) Amineptine 523
(7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic 524
acid); 525
(3) N-benzylpiperazine (also known as BZP and 526
1-benzylpiperazine); 527
(4) Cathinone; 528
(5) 4,4'-Dimethylaminorex, also known as 4,4'-DMAR or 529
4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 530
4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine); 531
(6) Fenethylline; 532
(7) Mesocarb 533
(N-phenyl-N' -(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3- 534
ium-5-yl)carbamimidate); 535
(8) Methcathinone; 536
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 23 (MCL\KP)

(9) Methiopropamine 537
(N-methyl-1-(thiophen-2-yl)propan-2-amine)); 538
(10) 4-methylaminorex (also known as 539
2-amino-4-methyl-5-phenyl-2-oxazoline); 540
(11) N-ethylamphetamine; 541
(12) Any material, compound, mixture or preparation 542
which contains any quantity of N,N-dimethylamphetamine. (Other 543
names include: N,N,-alpha-trimethyl-benzeneethanamine and 544
N,N-alpha-trimethylphenethylamine); 545
(13) Synthetic cathinones. (A) Unless listed in 546
another schedule, any compound other than bupropion that is 547
structurally derived from 2-Amino-1-phenyl-1-propanone by 548
modification in any of the following ways: 549
(i) By substitution in the phenyl ring to any 550
extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide 551
substituents, whether or not further substituted in the phenyl 552
ring by one or more other univalent substituents; 553
(ii) By substitution at the 3-position with 554
an alkyl substituent; 555
(iii) By substitution at the nitrogen atom 556
with alkyl or dialkyl groups, or by inclusion of the nitrogen atom 557
in a cyclic structure. 558
(B) The compounds covered in this paragraph (10) 559
include, but are not limited to, any material, compound, mixture 560
or preparation which contains any quantity of a synthetic 561
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 24 (MCL\KP)

cathinone found in any of the following compounds, whether or not 562
substituted to any extent, or any of these compounds which contain 563
any synthetic cathinone, or salts, isomers, or salts of isomers, 564
whenever the existence of such salts, isomers or salts of isomers 565
is possible, unless specifically excepted or listed in another 566
schedule: 567
(i) 4-methyl-N-ethylcathinone ("4-MEC"); 568
(ii) 4-methyl-alpha-pyrrolidinopropiophenone 569
("4-MePPP"); 570
(iii) Alpha-pyrrolidinopentiophenone 571
("α-PVP"); 572
(iv) 1-(1,3-benzodioxol-5-yl)-2- 573
(methylamino)butan-1-one ("butylone"); 574
(v) 2-(methylamino)-1-phenylpentan-1-one 575
("pentedrone"); 576
(vi) 1-(1,3-benzodioxol-5-yl)-2- 577
(methylamino)pentan-1-one ("pentylone"); 578
(vii) 4-fluoro-N-methylcathinone ("4-FMC"); 579
(viii) 3-fluoro-N-methylcathinone ("3-FMC"); 580
(ix) 1-(naphthalen-2-yl)-2- (pyrrolidin-1-yl) 581
pentan-1-one ("naphyrone"); 582
(x) Alpha-pyrrolidinobutiophenone ("α-PBP"); 583
(xi) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino) 584
-pentan-1-one (N-ethylpentylone, ephylone); 585
(14) a-PiHP 586
H. B. No. 864 *HR43/R112* ~ OFFICIAL ~
26/HR43/R112
PAGE 25 (MCL\KP)
ST: Kratom; add to Schedule I of the Uniform
Controlled Substances Act.
4-methyl-1-phenyl-2-pyrrolidin-1-yl)pentan-1-one, also known as 587
alpha-PiHP; and 588
(15) 3–MMC 589
2-methylamino)-1-3-methylphenyl)propan-1-one, also known as 590
3-methylmethcathinone. 591
(16) (A) Mitragynine; and 592
(B) 7-hydroxymitragynine. 593
SECTION 2. This act shall take effect and be in force from 594
and after July 1, 2026. 595